Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Proto Labs (PRLB) EBT Margin (2016 - 2025)

Proto Labs (PRLB) has disclosed EBT Margin for 15 consecutive years, with 5.97% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 620.0% to 5.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.83% through Dec 2025, up 90.0% year-over-year, with the annual reading at 5.83% for FY2025, 90.0% up from the prior year.
  • EBT Margin hit 5.97% in Q4 2025 for Proto Labs, down from 7.57% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 13.2% in Q2 2021 to a low of 100.95% in Q4 2022.
  • Historically, EBT Margin has averaged 0.58% across 5 years, with a median of 5.75% in 2021.
  • Biggest five-year swings in EBT Margin: plummeted -11141bps in 2022 and later skyrocketed 10890bps in 2023.
  • Year by year, EBT Margin stood at 10.46% in 2021, then tumbled by -1065bps to 100.95% in 2022, then surged by 108bps to 7.95% in 2023, then tumbled by -103bps to 0.23% in 2024, then skyrocketed by 2679bps to 5.97% in 2025.
  • Business Quant data shows EBT Margin for PRLB at 5.97% in Q4 2025, 7.57% in Q3 2025, and 4.94% in Q2 2025.